1. Fontana, A.; Marchiori, F.; Moroder, L. (1966) Uso di N-dinitrofenilsulfenil-amminoacidi nella sintesi di peptidi. Chim. Ind. 48, 1227.
  2. Scoffone, E.; Rocchi, R.; Marchiori, F.; Moroder, L.; Marzotto, A. (1966) Sintesi degli analoghi Tyr8,Orn10 e Lys10 dell´eicosapeptide N-terminale della ribonucleasi A. Chim. Ind. 48, 1223-1224.
  3. Scoffone, E.; Marchiori, F.; Moroder, L.; Rocchi, R.; Scatturin, A.; Tamburro, A. M. (1967) Studi conformazionali su ribonucleasi parzialmente sintetiche. Chim. Ind. 49, 535.
  4. Scoffone, E.; Marchiori, F.; Moroder, L.; Rocchi, R. (1967) L´impiego della sintesi chimica nell´indagine conformazionale della ribonucleasi A. Chim. Ind. 49, 968-969.
  5. Rocchi, R.; Marchiori, F.; Moroder, L.; Borin, G.; Scoffone, E. (1969) Effetto di alcune modifiche nelle posizioni 4, 5, 6 e 7 delle ribonucleasi S‘. Chim. Ind. 51, 518.
  6. Marchiori, F.; Rocchi, R.; Moroder, L.; Borin, G.; Scoffone, E. (1969) Sull‘ importanza del carattere aromatico del residuo in posizione 8 nell‘ associazione tra peptide S e proteina S. Chim. Ind. 51, 518.
  7. Borin, G.; Moroder, L.; Marchiori, F.; Scoffone, E. (1972) Sintesi di frammenti peptidici corrispondenti all‘ intera sequenza primaria dell‘ iso-I-citocromo c di lievito. Chim. Ind. 54, 1139.
  8. Scoffone, E.; Borin, G.; Moroder, L.; Marchiori, F. (1972) Approach to the total synthesis of a protein: baker‘s yeast iso-1-cytochrome c. Acta Vitaminol. Enzymol.26, 204.
  9. Filippi, B.; Borin, G.; Marchiori, F.; Moroder, L.; Scoffone, E. (1974) Relazione tra attività e struttura in RNase S‘ parzialmente sintetiche. Studi cinetici e conformazionali su (Orn-10,Asn-14)-RNase S‘. Chim. Ind. 56, 850.
  10. Wünsch, E.; Wendlberger, G.; Hallett, A.; Jaeger, E.; Moroder, L.; Thamm, P.; Wilschowitz, L. (1976) Total synthesis of human big-gastrin-I and the Leu32-analogue. Acta Hepato-Gastroenterol. 23, 303.
  11. Sprügel, W.; Mitznegg, P.; Domschke, W.; Domschke, S.; Wünsch, E.; Moroder, L.; Demling, L. (1977) Direct inhibitory effects of enkephalins on contractile responses in the guinea pig ileum. Gastroenterology72, 1135.
  12. Moroder, L.; Jaeger, E.; Wünsch, E.; Schulz, I.; Schlegel, W.; Bataille, D. (1977) Biological and immunological properties of secretin analogues. Acta Hepato-Gastroenterol. 24, 489.
  13. Wünsch, E.; Moroder, L.; Thamm, P.; Brown, J.; Pederson, R. (1978) GIP structure - a still unsolved problem. Acta Hepato-Gastroenterol. 25, 504.
  14. Moroder, L.; Hallett, A.; Thamm, P.; Wilschowitz, L.; Brown, J. C.; Wünsch, E. (1978) Studies on gastric inhibitory polypeptide. Synthesis of the octatriacontapeptide GIP-1-38 with full insulinotropic activity. Scand. J. Gastroenterol. 13 (Suppl. 49) 129.
  15. Lehnert, P; Forell, M. M.; Jaeger, E.; Moroder, L.; Wünsch, E. (1979) Comparison of the biological activity of secretin and some related peptides. Danish Med. Bull. 26, Suppl. 1,  20.
  16. Propst, F.; Moroder, L.; Wünsch, E.; Hamprecht, B. (1979) Influence of peptide hormones on the level of cyclic AMP in neuroblastoma x glioma hybrid cells. Acta Neurol. Belgica79, 57.
  17. Moroder, L.; Gemeiner, M.; Göhring, W.; Jaeger, E.; Knof, S.; Scharf, R.; Thamm, P.; Wilschowitz, L.; Gardner, J. D.; Wünsch, E. (1980) A new synthesis of cholecystokinin-pancreozymin active peptides. Acta Hepato-Gastroenterol. 27, 72.
  18. Gemeiner, M.; Moroder, L.; Pradayrol, L.; Wünsch. E. (1980) Total synthesis of porcine big-somatostatin (somatostatin-28) Reg. Pept. Suppl. 1, S41.
  19. Peggion, E.; Jaeger, E.; Knof, S.; Moroder, L.; Wünsch, E. (1980) Circular dichroism studies on the conformation of gastrin related peptides. Regul. Pept. Suppl.1, S86.
  20. Moroder, L.; Gemeiner, M.; Pradayrol, L.; Wünsch, E. (1981) On the identity of natural and synthetic somatostatin-28. Acta Hepato-Gastroenterol. 28, 67.
  21. Valet, G.; Raffael, A.; Moroder, L.; Wünsch, E.; Ruhenstroth-Bauer, G. (1981) Fast intracellular pH determination by flow-cytometry. Cytometry2, 133-134.
  22. Valet, G.; Raffael, A.; Ormerod, M.; Warnecke, H.; Benker, G.; Moroder, L.; Wünsch, E.; Ruhenstroth-Bauer, G. (1981) Antigens and the intracellular pH as sensitive markers for flow cytometric detection of tumor cells. Cytometry2, 134.
  23. Lehnert, P.: Forell, M. M.; Spiessl, W.; Jaeger, E.; Moroder, L.; Wünsch, E. (1982) Interaction of secretin analogs and of VIP with secretin in the dog pancreas. Digestion25, 49.
  24. Esteve, J. P.; Vaysse, N.; Susini, C.; Fourmy, D.; Kunsch, J. M.; Pradayrol, L.; Wünsch, E.; Moroder, L.; Ribet, A. (1982) Bimodal regulation of pancreatic exocrine function in vitro by somatostatin-28. Digestion25, 26-27.
  25. Moroder, L.; Göhring, W.; Borin, G.; Bali, J. P.; Previero, A.; Wünsch, E. (1982) Gastrin-related peptides and their biological properties. Acta Hepato-Gastroenterol. 29, 90.
  26. Koulischer, D.; Moroder, L.; Deschodt-Lanckman, M. (1982) Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro. Arch. Int. Physiol. Biochim. Biophys. 90, B42-B43.
  27. Magous, R.; Bali, J.-P.; Moroder, L. (1982) Gastrin receptor – Structure-binding relationships with peptides from gastrin family. Biology of the Cell, 45, 199.
  28. Antoniotti, H.; Fagot-Revurat, P.; Pradayrol, L.; Chayvialle, J. A.; Moroder, L.; Wünsch, E.; Ribet, A. (1982) Specific determination of the N-terminal fragment of somatostatin-28 in rat pancreatic tissue. Digestion25, 14.
  29. Kalbacher, H.; Moroder, L.; Wünsch, E. (1983) Chemical aspects for the improvement of immunoassays of peptide hormones (Chemische Aspekte zur Verbesserung von Immunoassays für Peptidhormone). Hoppe-Seyler‘s Z. Physiol. Chem. 364, 344.
  30. Antoniotti, H.; Fagot-Revurat, P.; Chayvialle, J. A.; Moroder, L.; Pradayrol, L.; Wünsch, E.; Ribet, A. (1983) Measurement of somatostatins in rat tissues using sequence specific radioimmunoassays. Regul. Pept. 2, Suppl., S45.
  31. Laburthe, M.; Amiranoff, B.; Boige, N.; Rouyer-Fessard, C.; Tatemoto, K.; Moroder, L. (1983) GRF interaction with VIP receptors in human and rat intestinal epithelial membranes. Comparison with PHI and secretin. Regul. Pept.6, 314.
  32. Esteve, J. P.; Vaysse, N.; Susini, C.; Fourmy, D.; Kunsch, J. M.; Pradayrol, L.; Wünsch, E.; Moroder, L.; Ribet, A. (1983) Regulation of in vitro exocrione pancreatic function by somatostatin. Diabetes & Metabolism9, R15. (No PDF)
  33. Pradayrol, L.; Antoniotti, H.; Fagot-Revurat, P.; Chayvialle, J. A.; Moroder, L.; Wünsch, E.; Ribet, A. (1983) Activation of somatostatin precursors in rat-tissues by conjugation of gel-permeation chromatography and sequence specific RIA. Gastroenterology84, 1276.
  34. Geiger, R.; Moroder, L.; Wünsch, E. (1984) Cloning - an efficient improvement in immunoassays? Hepato-Gastroenterol. 31, 94.
  35. Gespach, C.; Bataille, D.; Vauclin, N.; Moroder, L.; Wünsch, E.; Rosselin, G. (1985) Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology. Regul. Pept.3 Suppl. 3, S30.
  36. Moroder, L.; Wünsch, E. (1985) Methodological aspects of the chemical synthesis of VIP-Secretin-Peptides. Regul. Pept.3 Suppl.3, S4.
  37. Bali, J.-P.; Magous, R.; Lignon, M. F.; Dubreuil, P.; Galleyrand, J. C.; Moroder, L.; Martinez, J, (1987) Influence of peptide length and sulfation of gastrin on the acid secretory potency and receptor affinity. Gastroenterol. Clin. Biol. 11, 737.
  38. Wünsch, E.; Moroder, L.; Lerchen, H.-G.; Svoboda, M.; Christophe, J. (1989) Biological properties of 23-serine (O-2-desoxy-a-D-galactosyl)-CCK-[23-33] and CCK-[22-33] Hepato-gastroenterol. 36, 40.
  39. Christophe, J.; Winand, J.; Poloczek, P.; Delporte, C.; Svoboda, M.; Moroder, L. (1990) Cholecystokinin receptors are distinguished kinetically by Biotinyl-Tyr-Gly-(Thr-28,Nle-31)-CCK-(25-33) (BTG-CCK-9) in rat pancreatic acini. Digestion 46, 132-133.
  40. Mronga, S.; Kessler, H.; Müller, G.; Kurz, G.; Moroder, L.; Wünsch, E. (1991) Solution structure determination of a hinge peptide derivative. J. Cell Biochem. Suppl (15 Part G), 88.
  41. Moroder, L.; Weyher, E.; D´Ursi, A.; Picone, D.; Temussi, P. A. (1992) CD and NMR conformational studies on cholecystokinin peptides. Regul. Pept. 40, 213.
  42. Terness, P.; Moroder, L.; Marx, U.; Rölcke, D.; Welschof, M. (1993) Igg-mediated suppression of autoimmune B-cells – An idiotype-independent immunoregularory mechanism. J. Immunol. 150 (8): A240, Part 2.
  43. Dufresne, M,: Escrieut, C.; Clerc, P.; Saillan, C.; Kennedy, K.; Fanjul, M.; Mengod, G.; Real, F.; Moroder, L.; Vaysse, N.; Fourmy, D. (1995) Predominat expression of CCK-B/gastrin receptor in human pancreas. Digestion 56, 280.
  44. Terness, P.; Welschof, M.; Kohl, I.; Moroder, L.; Navolan, D.; Dufter, Ch.; Little, M.; Opelz, G.           (1997) Epitope mapping and gene structure analysis of a human immunosuppressive natural TgG-anti-IgG autoantibody. Immunol. Lett. 56, 369.
  45. Gales, C.; Escrieut, C.; Fourmy, D.; Maigret, B.; Moroder, L.; Vaysse, N.; Poirot, S. S. (1998) Identification of a key residue involved in the activation of the cholecystokinin B receptor. Gastroenterology, 114, (4), A1144, G4681.
  46. Gigoux, V.; Escrieut, C.; Poirot, S.; Bouisson, M.; Maigret, B.; Fehrentz, J.-A.; Martinez, J.; Moroder, L.; Vaysse, N.; Fourmy, D. (1998) Mapping of the CCK binding site of the CCK-A receptor and analysis of the interactions that stabilize its active state. Digest. Diseases Sci. 43: 1884.
  47. Poirot, S. S; Gales, C.; Escrieut, C.; Fourmy, D.; Maigret, B.; Moroder, L.; Vaysse, N. (1999) Asn367 and asn391 within the highly conserved motif NPXXY of the rat cholecystokinin A and B receptors are essential to switch their receptors to an active conformation for different transduction pathways. Gastroenterology, 116, Part 2, G2780.
  48. Moroder, L.; Friedrich, R.; Ottl, J. (2000) Heterotrimeric collagen peptides: synthesis and conformational properties. Abstr. Papers Amer. Chem. Soc. 219, 573-Poly Part 2.
  49. Escrieut, C.; Maigret, B.; Sivente-Poirot., S.; Gigoux, V.; Martinez, J.; Moroder, L.; Bignon, E.; Vaysse, N.; Fourmy, D. (2000) Identification of residues of the human CCK-A receptor that are in interaction with the C-terminal phenylalanine of CCK. Gastroenterology, 118, 4, A305.
  50. Fourmy, D.; Escrieut, C.; Maigret, B.; Verrier, S.; Silvente-Poirot, S.; Moroder, L.; Martinez, J.; Pradayrol, L. (2000) Identification of the human CCK-A receptor binding sites for peptide and non-peptide agonists and antagonists. Regul. Pept. 94 (1-3), 31.
  51. Dufresne, M.; Esteve, J.-P.; Tassa, A.; Arnould, M.; Escherich, A.; Moroder, L.; Pradayrol, L.; Fourmy, D. (2000) The G-protein coupled CCB/G receptor physically associates with PLCg1. Regul. Pept. 94 (1-3), 72.
  52. Gales, C.; Kowalski-Chauvel, A.; Dufour, M. N.; Seva, C.; Moroder, L.; Pradayrol, L.; Vaysse, N.; Fourmy, D.; Silvente-Poirot, S. (2000) Mutation of Asn391 within the highly conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor. Gastroenterology, 118 , (4) A305 Part 1 Suppl. 1688.
  53. Fiori, S.; Barth, D.; Friedrich, R.; Schütt, M.; Moroder, L. (2000) Conformational analysis of trimeric collagen peptides crosslinked with a cystine-knot. J. Pept. Sci. 6, S151.
  54. Kerek, F.; Apell, H.-J.; Stimac, R.; Freudemann, F.; Moroder, L.. (2000) Macrocyclic carbon suboxide adducts as putative structures of some highly active antirheumatic or cardiotonic factors of plant Origin. Phytomedicine 7, Suppl II, P153.
  55. Moroder, L.; Schaschke, N.; Loidl, G.; Groll, M.; Matschiner, G.; Sommerhoff, C. P.; Bode, W.; Huber, R. (2000) Multivalent inhibition of eucaryotic proteasomes and human b-tryptase. J. Pept. Sci. 6, S57.
  56. Renner, C.; Moroder, L.; Holak, T. (2000) Analytical solution to the Lipari-Szabo model based on the reduced spectral densitiy approximation offers a novel protocol for extracting motional parameter.Eur. Biophys. J.29, 4-5, 390.
  57. Schaschke, N.; Assfalg-Machleidt, I.; Machleidt, W.; Laßleben, T.; Sommerhoff, C. P.; Moroder, L. (2000) Targeting extracellular cathepsin B by effector-functionalized endo-epoxysuccinyl peptides.J. Pept. Sci. 6, S182.
  58. Sperl, S.; Jacob, U.; Arroyo de Prada, N.; Stürzebecher, J.; Wilhelm, O. G.; Bode, W.; Magdolen, V.; Huber, R.; Moroder, L. (2000) Design, synthesis and X-ray crystal structure of a new class of selective UPA-inhibitors. Fibrinolysis & Proteolysis14, Suppl. 1, 51.
  59. Spörlein, S.; Renner, C.; Behrendt, R.; Moroder, L.; Zinth, W.; Wachtveitl, J. (2000) Initial conformational dynamics in cyclic azobenzene peptides.Eur. Biophys. J. 29, 4-5, 273.
  60. van Neuren, A. S.; Schafferhans, A.; Moroder, L.; Müller, G.; Klebe, G. (2000) A new modelling approach towards GPCR-ligand complexes exploring antagonist binding site of the CCK-B receptor. J. Mol. Graph. Model. 18, 216.
  61. Stürzebecher, J.; Schweinitz, A.; Steinmetzer, T.; Künzel, S., Sperl, S.; Moroder, L. (2001) Novel-benzamidine-derived inhibitors of factor Xa. Ann. Hematol. 80 (Suppl. 1), A63.
  62. Probst, J. C.; Bürgle, M.; Foekens, J.; Kessler, H.; Magdolen, V.; Moroder, L.; Potthoff, N.; Schmalix, W.; Schmiedeberg, N.; Schmitt, M.; Setyono-Han, B.; Sperl, S.; Stürzebecher, J. (2001) Small molecule approach to inhibit the urokinase-type plasminogen activator system. Proc. Amer. Ass. Cancer Res. Ann. Meeting vol. 42, 69.
  63. Gales, C.; Berge, C.; Moroder, L.; Pradayrol, L.; Fourmy, D.; Silvente-Poirot, S. (2001) Selective activation of PKC-independent P42-P44 mitogen activating protein kinase pathway by a constitutive cholecystokinin 2 receptor mutant. FASEB J. 15, A572.
  64. Wosikowski, K.; Foekens, J.; Kopitz, C.; Krüger, A.; Magdolen, V.; Moroder, L.; Probst, J. C.; Sato, S.; Schmalix, W.; Schmitt, M.; Setyono-Han, B.; N.; Sperl, S.; Stürzebecher, J. (2002) Inhibitors of the urokinase-type plasminogen activator system. Proc. Amer. Ass. Cancer Res. Ann. Meeting vol. 43, 159.
  65. Sperl, S.; Moroder, L.; Setyono-Han, B.; Foekens, J.; Schmalix, W.; Wosikowski, K. (2002) Highly selective inhibitors of the urokinase-type plasminogen activator. Papers Amer. Chem. Soc. 224 089 MEDI Part.
  66. Barth, D.; Musiol, H.-J.; Renner, C.; Frank, S.; Engel, J.; Moroder, L. (2002) Synthesis of trimeric collagen peptides with artificial and natural cystine knot. J. Pept. Sci. 8 Suppl., 205 (P D72).
  67. Kaiser, M.; Groll, M.; Huber, R.; Moroder, L. (2002) Synthesis of TMC-95A analogs as reversible inhibitors of eucaryotic proteasome. J. Pept. Sci. 8 Suppl., 166 (P C81).
  68. Stella, L.; Mazzuca, C.; Palleschi, A.; Venanzi, M.; Formaggio, F.; Toniolo, C.; Moroder, L.; Pispisa, B. (2002) Mechanism of membrane permeabilization by the lipopeptaibol trichogin GA IV and its fluorescent analogues. J. Pept. Sci. 8 Suppl. 76 (L 77).
  69. Venanzi, M.; Palleschi, A.; Stella, L.; Valeri, A.; Formaggio, F.; Toniolo, C.; Moroder, L.; Pispisa, B. (2002) Structural features of linear peptides in solution carrying new fluorescent analogues of tryptophan. J. Pept. Sci. 8 Suppl., 199 (P D46).
  70. Gonscherowski, V.; Zahler, S.; Moroder, L.; Becker, B. F. (2002) Role of calpains in reperfusion injury and vascular permeability of isolated guinea pig hearts. Pflügers Arch. Eur. J. Physiol. 443 (Suppl. 1). S296-S297.
  71. Archer, E.; Escrieut, C.; Martinez, J.; Moroder, L.; Pradayrol, L.; Fourmy, D.; Maigret, B. (2002) Rhodopsin crystal: New template, more realistic models of G- protein-coupled-receptors? Regul. Pept. 108, 12.
  72. Schütt, M.; Milbradt, A. G.; Reif, M.; Moroder, L.; Renner, C. (2003) Light-induced two-state structural transition of a cyclic PDI-related azobenzene-peptide. Biopolymers (Pept. Sci.), 71, 332 (P131).
  73. Mueller, M. M.; Musiol, H.-J.; Moroder, L. (2003) Synthesis of guanidine compounds using resin-bound guanidinylating reagents. Biopolymers (Pept. Sci.), 71, 362 (P269).
  74. Kaiser, M.; Milbradt, A. G.; Renner, C.; Assfalg-Machleidt, I.; Groll, M.; Huber, R.; Moroder, L. (2003) Cyclic biphenyl ether tripeptides as proteasome inhibitors. Biopolymers (Pept. Sci.), 71, 396 (P432).
  75. Kaiser, M.; Groll, M.; Siciliano, C.; Assfalg-Machleidt, I.; Weyher, E.; Kohno, J.; Milbradt, A. G.; Renner, C.; Huber, R.; Moroder, L. (2004) Structural determination for 20S proteasome inhibition by TMC-95A. J. Pept. Sci.10, Suppl. 2, 211 (P350).
  76. Milbradt, A. G.; Moroder, L.; Renner, C. (2004) The multiple cysteine-containing head domain of minicollagen from Hydra nematocysts folds oxidatively into a compact globular structure. J. Pept. Sci. 10 Suppl. 2, 229 (P417).
  77. Moroder, L. (2004) Disulfides in peptides and proteins. A personal challenge from past to present. J. Pept. Sci.10 Suppl. 2, 89.
  78. Musiol, H.-J.; Kaiser, M.; Dong, S.; Moroder, L. (2004) Click and ligation chemistry for the synthesis of GPI-anchored membrane proteins.J. Pept. Sci. 10 Suppl. 2, 200 (P304).
  79. Pfizer, J.; Assfalg-Machleidt, I.; Machleidt, W.; Moroder, L.; Schaschke, N. (2004) Primed site probing of papain-like cysteine protease. J. Pept. Sci. 10 Suppl. 2, 214 (P360).
  80. Archer, E.; Escrieut, C.; Martinez, J.; Moroder, L.; Maigret, B.; Logsdon, C.; Kopin, A.; Seva, C.; Dufresne, M.; Pradayrol, L.; Fourmy, D. (2004) Molecular mechanism underlying partail agonism mediated by G-protein-coupled receptor, human cholecystokinin-1 receptor. Regul. Pept. 122 (1) A2, 5
  81. Archer, E.; Escrieut, C.; Dufresne, M.; Seva, C.; Pradayrol, L.; Moroder, L.; Maigret, B.; Fourmy, D. (2004) Modeled stucture of a G-protein-coupled receptor, the human cholecystokinin-1 receptor. Regul. Pept. 122, 5, Abstr. 3, 5.
  82. Vatinel, S.; Lopez, F.; Esteve, J. P.; Monsarrat, B.; Moroder, L.; Pradayrol, L.; Dufresne, M.; Fourmy, D.; Seva, C. (2004) Proteomics approaches to identify signalling complexes interacting with the CCK2 receptor C-terminus. Regul. Pept. 122, 46, Abstr. A148.
  83. Mulinacci, B.; Breithaupt, C.; Pal, P. P.; Budisa, N.; Pazzagli, M.; Mazzanti, B.; Rovero, P.; Moroder, L.; Papini, A. M. (2005) Cross-reactivity studies of rMOG(ED) with synthetic putative autoantigens CSF114(Glc) and [N-31(Glc)]hMOG(30-50) in multiple sclerosis patients' sera. Biopolymers (Pept. Sci.), 80 Suppl., 484.
  84. Moroder, L. (2005) Peptides in the days of photonics. Biopolymers (Pept. Sci.), 80 Suppl., 491, L20.
  85. Löweneck, M.; Dong, S. L.; Schrader, T. E.; Schreier, W. J.; Zinth, W.; Moroder, L.; Renner, C (2005) A photo-controlled b-hairpin. Biopolymers (Pept. Sci.), 80 Suppl. , 547.
  86. Barazza, A.; Renner, C.; Willem, M.; Moroder, L. (2005) Cyclic phenylstatine-based tetrapeptides as inhibitors of b-secretase. Biopolymers (Pept. Sci.), 80 Suppl., 554.
  87. Kusebauch, U.; Moroder, L.; Renner, C. (2005) Towards photo-controlled collagens. Biopolymers (Pept. Sci.), 80 Suppl., 575.
  88. Milbradt, A. G.; Boulègue, C.; Moroder, L.; Renner, C. (2005) The two cysteine rich head domains from hydra minicollagen show different disulfide bridges and different novel folds despite identical cysteine sequence pattern. Biopolymers (Pept. Sci.), 80 Suppl., 590.
  89. Sinner, E. K.; Hötzer, L.; Leidig, C.; Wiltschi, B.; Krupka, S.; Oesterhelt, D.; Moroder, L. (2005) Functional characterization of synthetic collagen for cell adhesion studies on artificial ECM surfaces. Abstr. Papers Amer. Chem. Soc., 229, U632, 019-COLL Part 1.
  90. Krüger, A.; Banke, I.; Arlt, M.; Stemberger, A.; Sperl, S.; Stürzebecher, J.; Amirkhosravi, A.; Müller, M.; Mororder, L. (2005) Efficient inhibition of experimental metastasis and prolongation of survival by a potent Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity. Proc. Amer. Ass. Cancer Res. Ann. Meeting vol. 46, 64.
  91. Langer, I.; Tikhonova, I.; Vatinel, S.; Ferrand, A.; Lopez, F.; Estève, J.-P.; Moroder, L.; Boulègue, C.; Fourmy, D. (2005) Evidence for a direct and functional interaction between the human CCK2 Receptor  and RGS2.Pancreatology, 5 (S1), 38.
  92. Tikhonova, I.; Langer, I.; Escrieut, C.; Boulègue, C.; Moroder, L.; Fourmy, D. (2005) Molecular dynamics study of interaction of modeled RGS2 protein structure with lipids bilayer. (2005) Eur. Biophys. J. 34, 627.
  93. del Pino, P.; Weiss, A.; Mentler, M.; Renner, C.; Moroder, L.; Bertsch, U.; Kretzschmar, H. A.; Parak, F. G. (2005) Characterization of the Cu(II) binding sites in the N-terminal domain of the prion protein. Eur. Biophys. J. 34 (6), 755.
  94. Langer, I.; Tikhonova, I.; Vatinel, S.; Ferrand, A.; Lopez, F.; Estève, J.-P.; Moroder, L.; Boulègue, C.;  Fourmy, D. (2005) Mise en évidence d’une interaction directe et fonctionnelle entre le récepteur CCK2 humain et la RGS2. Gastroentérologie Clinique et Biologique, 29, 701 (C8)
  95. Boulègue, C.; Milbradt, A. G.; Renner, C.; Moroder, L. (2006) Unexpected different disulfide connectivities of cysteine-rich peptides comprising identical cysteine pattern. J. Pept. Sci. 12, Suppl., 194.
  96. Kusebauch, U.; Cadamuro, S. A.; Musiol, H.-J.; Moroder, L.; Renner, C. (2006) Photo-control of the collagen triple helix. J. Pept. Sci. 12 Suppl., 199.
  97. Langer, I.; Tikhonova, I. G.; Boulègue, C.; Esteve, J.-P.; Vatinel, S.; Ferrand, A.; Pradayrol, L.; Moroder, L.; Robberecht, P.; Fourmy, D.. (2006) A new mechanism of G protein coupled receptor regulation through direct interaction between RGS2 and phosphorylated C-terminus of cholecystokinin receptor. Regul. Pept. 135, 140.
  98. Langer, I.; Tikhonova, I.G.; Boulègue, C.; Estève J.-P.; Vatinel, S.; Ferrand, A.; Pradayrol, L.; Moroder, L.; Robberecht, P.; Fourmy, D. (2006) Nouveau mécanisme de régulation d’un récepteur couplé aux protéines G par interaction entre la RGS2 et l’extrémité C-terminale phosphorylée du récepteur CCK2.Gastroentérologie Clinique et Biologique, 30, 75 (C6).
  99. Kusebauch, U.; Lorenz, L.; Cadamuro, S. A.; Musiol, H.-J.; Lenz, M. O.; Renner, C.; Wachtveitl, J.; Moroder, L. (2007) Light-switchable folding/unfolding of the collagen triple helix with azobenzene-containing model peptides. Biopolymers (Pept. Sci.), 88 Suppl., 532.
  100. Barth, L.; Sinner, E-K.; Oesterhelt, D.; Moroder, L. (2007) Homotrimeric collagen peptides as model systems for cell adhesion studies. Biopolymers (Pept. Sci.), 88 Suppl., 563.
  101. Götz, M. G.; Groll, M.; Kaiser, M.; Weyher, E.; Moroder, L. (2008) Macrocyclic peptidyl biaryl-ether inhibitors provide evidence for the catalytic versatility of the 20S proteasome Source. Abstracts of Papers of the American Chemical Society, MEDI 24, 35.
  102. Dong, S. L.; Merkel, L.; Musiol, H.-J.; Budisa, N.; Moroder, L. (2008) Advances in the stereoselective synthesis of homopropargylglycine. J. Pept. Sci. 14 Suppl. 49.
  103. Lorenz, L.; Kusebauch, U.; Moroder, L.; Wachtveitl, J. (2008) Azobenzene-mediated photomodulation of a collagen triple helix monitored by IR spectroscopy. J. Pept. Sci. 14 Suppl., 172.
  104. Moroder, L. (2008) Editorial: Making the Journal of Peptide Science more attractive for readers and authors. J. Pept. Sci. 14,889. 
  105. Moroder, L.; Röthlisberger, M. (2009) Editorial. J. Pept. Sci. 15, 57.
  106. Nuti, F. N.; Rizzolo, F.; Gori, F.; Chelli, M.; Rovero, P.; Moroder, L.; Papini, A. M. (2010) Microwave-assisted solid phase synthesis of collagen peptides. J. Pept. Sci. 16 Suppl., 79
  107. Moroder, L. (2012) Editorial. J. Pept. Sci. 18, 427.
  108. Moroder, L.; Diedrichsen, U. (2015) Editorial: Annniversary Issue. J. Pept. Sci. 21, 127.
  109. Moroder, L.; Diedrichsen, U. (2016) Editorial: A tribute to Stephen B.-H. Kent. Towards a new world of proteins enabled by chemical synthesis. J. Pept. Sci. 22, 245.
  110. Moroder, L.; Kiso, Y.; Diederichsen, U.; Teshima, T. (2017) Editorial (+ Suppl.File): Akabori. J. Pept. Sci. 23, 471. 
Web-View
Print Page
Open in new window
Estimated DIN-A4 page-width
Go to Editor View